Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Capital Expenditures (2016 - 2025)

Elevance Health (ELV) has disclosed Capital Expenditures for 16 consecutive years, with $293.0 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 9.01% to $293.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, down 11.15% year-over-year, with the annual reading at $1.1 billion for FY2025, 11.15% down from the prior year.
  • Capital Expenditures for Q4 2025 was $293.0 million at Elevance Health, down from $360.0 million in the prior quarter.
  • The five-year high for Capital Expenditures was $360.0 million in Q3 2025, with the low at $196.0 million in Q1 2025.
  • Average Capital Expenditures over 5 years is $295.3 million, with a median of $299.5 million recorded in 2022.
  • The sharpest move saw Capital Expenditures grew 24.51% in 2022, then dropped 29.75% in 2025.
  • Over 5 years, Capital Expenditures stood at $340.0 million in 2021, then fell by 12.35% to $298.0 million in 2022, then grew by 9.4% to $326.0 million in 2023, then decreased by 1.23% to $322.0 million in 2024, then fell by 9.01% to $293.0 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $293.0 million, $360.0 million, and $267.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.